Clinical trial
Implementing the 6th Generation Cardiac Troponin T: A Stepped Wedged Cluster-randomized Trial
NCT07936630 is registered in ClinicalTrials.gov with Rasmus Bo Hasselbalch as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Implementing the 6th Generation Cardiac Troponin T: A Stepped Wedged Cluster-randomized Trial
- Lead sponsor
- Rasmus Bo Hasselbalch
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- August 1, 2026
- Completion date
- July 31, 2028
- Enrollment
- 22,600 (estimated)
- Sites
- 22
Conditions
As the registry lists them; a condition with its own page is linked.
acs (acute coronary syndrome), mi(myocardial infarction)
Arms
As registered; 2 arms.
-
5th generation cardiac troponin T arm
Treatment is based on the use of the 5th generation troponin T assay
-
6th generation cardiac troponin T arm
Treatment is based on the use of the new 6th generation troponin T assay
Primary endpoints
Registered primary outcome measures; 1 primary.
-
Composite endpoint of death from any cause and MI, or revascularization within 6 months after admission (PCI and CABG).
This will exclude events during the index admission
Similar trials
Same condition (Acute Coronary Syndrome) and phase, most recent start first.
+406 more trials See the condition page